ReviewCells2022

FGFR Inhibitors in Cholangiocarcinoma-A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?

Paulina Chmiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.